TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group

Charlotte Levin Tykjær  Jørgensen; Christina Annette Bjerre; Bent Laursen Ejlertsen; Karsten D. Bjerre; Eva Balslev; Annette Bartels; Nils Brünner; Dorte L. Nielsen

doi:10.1186/1471-2407-14-360

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group

Charlotte Levin Tykjær Jørgensen, Christina Annette Bjerre, Bent Laursen Ejlertsen, Karsten D. Bjerre, Eva Balslev, Annette Bartels, Nils Brünner, Dorte L. Nielsen

6 Citationer (Scopus)

784 Downloads (Pure)

Originalsprog	Engelsk
Artikelnummer	360
Tidsskrift	B M C Cancer
Vol/bind	14
Antal sider	14
ISSN	1471-2407
DOI	https://doi.org/10.1186/1471-2407-14-360
Status	Udgivet - 22 maj 2014

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1186/1471-2407-14-360

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative groupForlagets udgivne version, 618 KB

Citationsformater

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer : results from a randomized phase III trial from the Danish breast cancer cooperative group. / Jørgensen, Charlotte Levin Tykjær; Bjerre, Christina Annette; Ejlertsen, Bent Laursen et al.

I: B M C Cancer, Bind 14, 360, 22.05.2014.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{07ba8e8fd6e74bc69030267929e2173d,

title = "TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group",

keywords = "TIMP-1, Gemcitabine, Docetaxel, Breast cancer, Prediction, Prognosis",

author = "J{\o}rgensen, {Charlotte Levin Tykj{\ae}r} and Bjerre, {Christina Annette} and Ejlertsen, {Bent Laursen} and Bjerre, {Karsten D.} and Eva Balslev and Annette Bartels and Nils Br{\"u}nner and Nielsen, {Dorte L.}",

year = "2014",

month = may,

day = "22",

doi = "10.1186/1471-2407-14-360",

language = "English",

volume = "14",

journal = "B M C Cancer",

issn = "1471-2407",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - TIMP-1 and responsiveness to gemcitabine in advanced breast cancer

T2 - results from a randomized phase III trial from the Danish breast cancer cooperative group

AU - Jørgensen, Charlotte Levin Tykjær

AU - Bjerre, Christina Annette

AU - Ejlertsen, Bent Laursen

AU - Bjerre, Karsten D.

AU - Balslev, Eva

AU - Bartels, Annette

AU - Brünner, Nils

AU - Nielsen, Dorte L.

PY - 2014/5/22

Y1 - 2014/5/22

KW - TIMP-1

KW - Gemcitabine

KW - Docetaxel

KW - Breast cancer

KW - Prediction

KW - Prognosis

U2 - 10.1186/1471-2407-14-360

DO - 10.1186/1471-2407-14-360

M3 - Journal article

C2 - 24884504

SN - 1471-2407

VL - 14

JO - B M C Cancer

JF - B M C Cancer

M1 - 360

ER -

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater